Enablers (band)

Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report

Retrieved on: 
Friday, February 23, 2024

This rebound occurred while clinical trial starts and funding returned to pre-pandemic levels, according to the new report, “Global Trends in R&D 2024: Activity, Productivity, and Enablers,” released by the IQVIA Institute for Human Data Science.

Key Points: 
  • This rebound occurred while clinical trial starts and funding returned to pre-pandemic levels, according to the new report, “Global Trends in R&D 2024: Activity, Productivity, and Enablers,” released by the IQVIA Institute for Human Data Science.
  • “This reflects industry-wide ingenuity and regulatory acceptance of innovative data and technology-driven enablers in trial design and digital trial execution.
  • R&D funding: In 2023, global funding of biopharmaceutical research and development increased to $72Bn, up from $61Bn in 2022.
  • The leading deals in 2023 included 11 that were over $5Bn and were focused on cancer, neurology and cardiovascular diseases.

New Report from Health Management Associates Analyzes the Expanding Landscape of Value-Based Entities

Retrieved on: 
Thursday, January 25, 2024

LANSING, Mich., Jan. 25, 2024 /PRNewswire/ -- Today, Health Management Associates (HMA) released a new report analyzing the landscape of emerging value-based entities and the implications for accelerating the adoption of accountable care.

Key Points: 
  • Researchers study the growing enabler market, consider benefits and risks, and propose guiding principles and policy recommendations
    LANSING, Mich., Jan. 25, 2024 /PRNewswire/ -- Today, Health Management Associates (HMA) released a new report analyzing the landscape of emerging value-based entities and the implications for accelerating the adoption of accountable care.
  • Despite their prevalence, there has been little formal research into the role, growth, and impact of these entities to date and publicly available information is limited.
  • The report offers a detailed overview of this evolving landscape by introducing a framework for classifying these entities and estimating the size of the market for the first time.
  • Authors examined providers' experiences selecting and collaborating with enablement partners and the role of these entities within Medicare accountable care models and the broader value movement.

MILE Advisory Releases Critical Data Report About Israel's Decarbonization Tech Ecosystem

Retrieved on: 
Wednesday, January 24, 2024

NEW YORK, Jan. 24, 2024 /PRNewswire/ -- MILE Advisory, a strategic consultancy firm specializing in energy and climate innovation, today released a report titled "Israel's Decarbonization Tech Ecosystem Report - 2023", focusing on the global decarbonization market and where Israel is succeeding and failing in aligning with global decarbonization demands. The report, based on extensive qualitative and quantitative data and research, is the first-of-its-kind survey of Israel's decarbonization technology efforts within its broader climate-tech ecosystem. This evaluation provides insights to inform private sector practices and government policies, guide VC investment strategies, and to foster startups that tackle real-world, demand-oriented problems.

Key Points: 
  • NEW YORK, Jan. 24, 2024 /PRNewswire/ -- MILE Advisory , a strategic consultancy firm specializing in energy and climate innovation, today released a report titled " Israel's Decarbonization Tech Ecosystem Report - 2023 " , focusing on the global decarbonization market and where Israel is succeeding and failing in aligning with global decarbonization demands.
  • The report, based on extensive qualitative and quantitative data and research, is the first-of-its-kind survey of Israel's decarbonization technology efforts within its broader climate-tech ecosystem.
  • Through meticulous and proprietary classifications from various sources and databases, MILE Advisory developed a curated list of Israeli technology startups operating in the decarbonization space.
  • The list, available separately from the report, provides the first-of-its-kind categorization of Israeli startups that focus directly on decarbonization and those that are enabling decarbonization efforts.

Enabling Pathways to a Sustainable Future: KAPSARC's Active Role at COP28

Retrieved on: 
Wednesday, November 29, 2023

With a central focus on global stocktake, mitigation, adaptation and finance the conference aims to provide actionable energy pathways, setting the stage for a resilient and inclusive climate future.

Key Points: 
  • With a central focus on global stocktake, mitigation, adaptation and finance the conference aims to provide actionable energy pathways, setting the stage for a resilient and inclusive climate future.
  • KAPSARC's engagement in COP28 spans across diverse and critical topics, reflecting the center's commitment to science-backed and data-driven discussions.
  • Role of LPG in Enabling the Just & Inclusive Energy Transition – December 5: Fateh Belaid, Fellow- KAPSARC.
  • The mission of KAPSARC is to advance Saudi Arabia's energy sector and inform global policies through evidence-based advice and applied research.

Enabling Pathways to a Sustainable Future: KAPSARC's Active Role at COP28

Retrieved on: 
Wednesday, November 29, 2023

With a central focus on global stocktake, mitigation, adaptation and finance the conference aims to provide actionable energy pathways, setting the stage for a resilient and inclusive climate future.

Key Points: 
  • With a central focus on global stocktake, mitigation, adaptation and finance the conference aims to provide actionable energy pathways, setting the stage for a resilient and inclusive climate future.
  • KAPSARC's engagement in COP28 spans across diverse and critical topics, reflecting the center's commitment to science-backed and data-driven discussions.
  • Role of LPG in Enabling the Just & Inclusive Energy Transition – December 5: Fateh Belaid, Fellow- KAPSARC.
  • The mission of KAPSARC is to advance Saudi Arabia's energy sector and inform global policies through evidence-based advice and applied research.

FTT Embedded Finance & Super Apps Returns to San Francisco Alongside Two Additional Co-Located Events

Retrieved on: 
Tuesday, August 22, 2023

This is the second year that the event is taking place in San Francisco, and the first year that the event will be co-located with two other events from VC Innovations: Customer Alpha and Future Identity .

Key Points: 
  • This is the second year that the event is taking place in San Francisco, and the first year that the event will be co-located with two other events from VC Innovations: Customer Alpha and Future Identity .
  • These events will take place at Hotel Kabuki, a boutique hotel and function venue in the heart of San Francisco’s Japantown on December 6-7, 2023.
  • FTT Embedded Finance & Super-Apps’ agenda will bring together a full community of collaborators in the space, including financial services providers, technology innovators and non-financial brands turning opportunity into reality.
  • “Embedded finance is, by definition, a collaborative opportunity, and we firmly believe that connecting different sectors in the digital world is the way forward for all our industries.

ERI Achieves Overall “A” Rating from Ellen MacArthur Foundation’s Circulytics Tool for Second Straight Year

Retrieved on: 
Tuesday, July 18, 2023

Circulytics, a free, award-winning, comprehensive tool developed by the Ellen MacArthur Foundation, measures circularity across a company’s entire operations, flags up areas for improvement, and highlights opportunities for strategic innovation.

Key Points: 
  • Circulytics, a free, award-winning, comprehensive tool developed by the Ellen MacArthur Foundation, measures circularity across a company’s entire operations, flags up areas for improvement, and highlights opportunities for strategic innovation.
  • Fundamentally, the tool helps companies transition to a circular way of doing business, versus conventional linear business models.
  • ERI received an A score across all themes in the Enablers category and an A- score in the Outcomes category, with an overall score of A.
  • “It is tremendously rewarding to have once again achieved an overall solid A Circulytics grade,” said ERI’s Chairman/CEO John Shegerian.

Remote Launches 2023 Remote Influencer Report

Retrieved on: 
Tuesday, April 11, 2023

SAN FRANCISCO, April 11, 2023 (GLOBE NEWSWIRE) -- Remote , the leader in building, managing and supporting global, distributed workforces, has today released its third annual report highlighting the most influential people in the world of remote and hybrid work.

Key Points: 
  • SAN FRANCISCO, April 11, 2023 (GLOBE NEWSWIRE) -- Remote , the leader in building, managing and supporting global, distributed workforces, has today released its third annual report highlighting the most influential people in the world of remote and hybrid work.
  • The 2023 Remote Influencer Report , which was created as a resource for companies developing their remote and hybrid working practices, as well as for workers who want to pursue a remote career, names 150 of the most impactful global thinkers and leaders in the future of work.
  • The three judges then whittled down Remote’s long list into the top 50 people in three categories that capture the evolution of remote work:
    Innovators - those who paved the way for remote work.
  • Brittnee Bond, Founder & Remote Work Consultant, Remote Collective | Coworking and Coliving Consultant, Bond Works
    16.

Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute

Retrieved on: 
Tuesday, March 14, 2023

In 2022, global clinical trial activity remained resilient even as the COVID-19 pandemic stretched through the year, with a 1% decline in non-COVID trial activity compared to 2021.

Key Points: 
  • In 2022, global clinical trial activity remained resilient even as the COVID-19 pandemic stretched through the year, with a 1% decline in non-COVID trial activity compared to 2021.
  • The report also found that clinical development productivity – a composite metric of success rates, clinical trial complexity and trial duration – increased dramatically in 2022, reversing a 10-year downward trend.
  • The global R&D ecosystem demonstrated impressive resilience during the continued pandemic with a relatively high level of clinical trial activity.
  • Clinical development productivity: The Clinical Development Productivity Index — a composite metric of success rates, clinical trial complexity and trial duration — rebounded in 2022, reversing a 10-year downward trend.